NRXP Annual CFF
$6.20 M
-$26.01 M-80.75%
31 December 2023
Summary:
As of January 23, 2025, NRXP annual cash flow from financing activities is $6.20 million, with the most recent change of -$26.01 million (-80.75%) on December 31, 2023. During the last 3 years, it has risen by +$2.95 million (+90.86%). NRXP annual CFF is now -90.23% below its all-time high of $63.46 million, reached on December 31, 2021.NRXP Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NRXP Quarterly CFF
$2.05 M
-$1.09 M-34.61%
30 September 2024
Summary:
As of January 23, 2025, NRXP quarterly cash flow from financing activities is $2.05 million, with the most recent change of -$1.09 million (-34.61%) on September 30, 2024. Over the past year, it has increased by +$1.66 million (+420.00%). NRXP quarterly CFF is now -94.53% below its all-time high of $37.52 million, reached on September 30, 2021.NRXP Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NRXP TTM CFF
$4.47 M
+$3.56 M+386.83%
30 September 2024
Summary:
As of January 23, 2025, NRXP TTM cash flow from financing activities is $4.47 million, with the most recent change of +$3.56 million (+386.83%) on September 30, 2024. Over the past year, it has increased by +$423.00 thousand (+10.44%). NRXP TTM CFF is now -93.79% below its all-time high of $72.01 million, reached on March 31, 2022.NRXP TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NRXP Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -80.8% | +420.0% | +10.4% |
| 3 y3 years | +90.9% | +7435.7% | -79.8% |
| 5 y5 years | +90.9% | - | - |
NRXP Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -90.2% | at low | -91.1% | +236.8% | -93.8% | +386.8% |
| 5 y | 5-year | -90.2% | +90.9% | -94.5% | +236.8% | -93.8% | +386.8% |
| alltime | all time | -90.2% | +90.9% | -94.5% | +236.8% | -93.8% | +386.8% |
NRx Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.05 M(-34.6%) | $4.47 M(+386.8%) |
| June 2024 | - | $3.14 M(+695.2%) | $919.00 K(-77.3%) |
| Mar 2024 | - | $395.00 K(-135.4%) | $4.05 M(-34.7%) |
| Dec 2023 | $6.20 M(-80.8%) | -$1.12 M(-25.6%) | $6.20 M(-64.4%) |
| Sept 2023 | - | -$1.50 M(-123.9%) | $17.44 M(-7.8%) |
| June 2023 | - | $6.27 M(+146.5%) | $18.91 M(+60.6%) |
| Mar 2023 | - | $2.54 M(-74.9%) | $11.78 M(-63.4%) |
| Dec 2022 | $32.21 M | $10.12 M(<-9900.0%) | $32.21 M(+45.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$28.00 K(-96.7%) | $22.09 M(-63.0%) |
| June 2022 | - | -$860.00 K(-103.7%) | $59.64 M(-17.2%) |
| Mar 2022 | - | $22.98 M(>+9900.0%) | $72.01 M(+13.5%) |
| Dec 2021 | $63.46 M(+1853.1%) | $1000.00(-100.0%) | $63.46 M(+0.0%) |
| Sept 2021 | - | $37.52 M(+225.9%) | $63.45 M(+144.6%) |
| June 2021 | - | $11.51 M(-20.2%) | $25.94 M(+79.8%) |
| Mar 2021 | - | $14.43 M | $14.43 M |
| Dec 2020 | $3.25 M | - | - |
FAQ
- What is NRx Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual CFF year-on-year change?
- What is NRx Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly CFF year-on-year change?
- What is NRx Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals TTM CFF year-on-year change?
What is NRx Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of NRXP is $6.20 M
What is the all time high annual CFF for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual cash flow from financing activities is $63.46 M
What is NRx Pharmaceuticals annual CFF year-on-year change?
Over the past year, NRXP annual cash flow from financing activities has changed by -$26.01 M (-80.75%)
What is NRx Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of NRXP is $2.05 M
What is the all time high quarterly CFF for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly cash flow from financing activities is $37.52 M
What is NRx Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, NRXP quarterly cash flow from financing activities has changed by +$1.66 M (+420.00%)
What is NRx Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of NRXP is $4.47 M
What is the all time high TTM CFF for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high TTM cash flow from financing activities is $72.01 M
What is NRx Pharmaceuticals TTM CFF year-on-year change?
Over the past year, NRXP TTM cash flow from financing activities has changed by +$423.00 K (+10.44%)